Fedratinib Hydrochloride and Isoniazid Injection

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration with dual CYP450 3A4 and 2C19 inhibitors may increase the plasma concentrations of fedratinib, which is a substrate of these isoenzymes. However, clinical data evaluating the interaction are not available. MANAGEMENT: According to the product labeling, concomitant use of fedratinib with dual CYP450 3A4 and 2C19 inhibitors should be avoided. References "Product Information. Inrebic (fedratinib)." Celgene Corporation, Summit, NJ.

GENERALLY AVOID: Coadministration with dual CYP450 3A4 and 2C19 inhibitors may increase the plasma concentrations of fedratinib, which is a substrate of these isoenzymes. However, clinical data evaluating the interaction are not available.

MANAGEMENT: According to the product labeling, concomitant use of fedratinib with dual CYP450 3A4 and 2C19 inhibitors should be avoided.

Fedratinib Hydrochloride

Generic Name: fedratinib

Brand name: Inrebic

Synonyms: Fedratinib

What is Fedratinib Hydrochloride?

Isoniazid Injection

Generic Name: isoniazid

Brand name: Nydrazid

Synonyms: Isoniazid

What is Isoniazid Injection?